• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4643727)   Today's Articles (1360)   Subscriber (50646)
Download
Number Citation Analysis
51
Li HS, Liu C, Xu F, Lei SY, Wang Y. 1006P RANKL drives malignant phenotypes and poor prognosis in KRAS-mutated lung adenocarcinoma. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
52
Wu L, Wang J, Chen B, Pu X, Li J, Liu L, Wang Q, Xu Y, Xu L, Xu F, Li K. EP08.02-161 An Exploratory Study on Biomarkers Related to Primary Resistance Of EGFR-TKIs Therapy in Lung Cancer. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
53
Wu L, Pu X, Lin G, Xiao M, Lin J, Wang Q, Kong Y, Yan X, Xu F, Xu Y, Li J, Li K, Chen B, Wen X, Tan Y. EP08.01-094 A Phase II Study of Camrelizumab combined with Apatinib and Albumin Paclitaxel in Advanced Non-squamous NSCLC (CAPAP-lung). J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
54
Wu L, Chen B, Wang J, Pu X, Li J, Wang Q, Liu L, Xu Y, Xu L, Kong Y, Li K, Xu F. EP08.01-093 ICI in Combination With Chemotherapy or Anti-angiogenic Agents as Second-Line Orbeyondtreatment for Advanced Non-small Cell Lung Cancer. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
55
Wu L, Pu X, Chen L, Wang Z, Liu Y, Li K, Kong Y, Xu F, Li J, Xu L, Xu Y, Tang C, Xiao L, Liu P. EP08.01-095 Efficacy and Safety of Combining Endostar with Camrelizumab plus Chemotherapy in Advanced NSCLC Patients: A Multi-Center Retrospective Study. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
56
Zhou Q, Li J, Wang J, Yang L, Fang J, Dong X, Yi T, Min X, Xu F, Chen J, Zhong D, Bai J, Liu L, Zeng A, Tang J, Wu H, Luo X, Yu J, Su W, Wu YL. EP08.02-063 SANOVO: A Phase 3 Study of Savolitinib or Placebo in Combination with Osimertinib in Patients with EGFR-mutant and MET Overexpressed NSCLC. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
57
Mol BW, Afnan M, Kemper JM, Xu F, Liu G, Xue L, Bai X, Liao H, Xue S, Zhao S, Xia L, Scott J, Morbeck D, Liu Y. O-008 Low grade blastocysts result in healthy live births and should not be discarded. Hum Reprod 2022. [DOI: 10.1093/humrep/deac104.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
58
Bu XX, Qiu WJ, Zhang HW, Gao XL, Zhan X, Chen T, Xu F, Liu YC, Gu XF, Han LS. [Disease spectrum analysis of children with inherited metabolic diseases detected by gas chromatography-mass spectrometry of urinary organic acids]. ZHONGHUA ER KE ZA ZHI = CHINESE JOURNAL OF PEDIATRICS 2022;60:522-526. [PMID: 35658356 DOI: 10.3760/cma.j.cn112140-20220117-00056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
59
Xu F, Lin W, Carmichael S, Bulsara S, Iannarelli J, Eaker S. Process Development and Manufacturing: Late Breaking Abstract: SCALABLE AND AUTOMATED END-TO-END WORKFLOW FOR TUMOR INFILTRATING LYMPHOCYTE (TIL) MANUFACTURING. Cytotherapy 2022. [DOI: 10.1016/s1465-3249(22)00479-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
60
Han Y, Zhi WH, Fan SP, Yan D, Xu F. [Risk factors of residual tumor in single small hepatocellular carcinoma after thermal ablation treatment]. ZHONGHUA NEI KE ZA ZHI 2022;61:543-547. [PMID: 35488605 DOI: 10.3760/cma.j.cn112138-20211004-00675] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
61
Xu F, Shi RJ, Zhang JJ, Song YL, Liu LL, Han ZH, Wang JM, Li YH, Feng CH, Li LJ. First Report of Microdochium nivale and M. majus Causing Brown Foot Rot of Wheat in China. PLANT DISEASE 2022;106:1523. [PMID: 34713726 DOI: 10.1094/pdis-08-21-1722-pdn] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
62
Wang Y, Yang G, Xu H, Zhang S, Yang Y, Xu F, Lei S, Ai X, Li H, Hao X, Li J. 15P Preliminary results of histone deacetylase inhibitor tucidinostat combined with PD-1 inhibitor sintilimab in non-small cell lung cancer failed to standard therapies. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.02.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
63
Yang K, Han H, Li Y, Ye J, Xu F. Significance of miRNA in enhancement of flavonoid biosynthesis. PLANT BIOLOGY (STUTTGART, GERMANY) 2022;24:217-226. [PMID: 34806280 DOI: 10.1111/plb.13361] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Accepted: 10/15/2021] [Indexed: 05/20/2023]
64
Li YD, Zhen WL, Weng SR, Hu HJ, Niu R, Yue ZL, Xu F, Zhu WK, Zhang CJ. Interface effects of Schottky devices built from MoS2and high work function metals. JOURNAL OF PHYSICS. CONDENSED MATTER : AN INSTITUTE OF PHYSICS JOURNAL 2022;34:165001. [PMID: 35105834 DOI: 10.1088/1361-648x/ac50db] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/28/2021] [Accepted: 02/01/2022] [Indexed: 06/14/2023]
65
Wang N, Qin L, Zhang J, Xiao Y, Liu K, Cui Y, Xu F, Ren W, Yuan Y, Ning S, Zeng M, Ye X, Liang N, Xing C, Liu J. POS-838 PRE-CLINICAL RESEARCH OF HUMAN AMNION-DERIVED MESENCHYMAL STEM CELLS AND ITS FIRST CLINICAL TREATMENT FOR A SEVERE UREMIC CALCIPHYLAXIS PATIENT. Kidney Int Rep 2022. [DOI: 10.1016/j.ekir.2022.01.875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
66
Zhong PP, Jin YL, Wang XL, Xu F, Zhang J, He CY. [Primary endometrial squamous cell carcinoma with endometrial atypical hyperplasia: report of a case]. ZHONGHUA BING LI XUE ZA ZHI = CHINESE JOURNAL OF PATHOLOGY 2022;51:74-76. [PMID: 34979763 DOI: 10.3760/cma.j.cn112151-20210524-00371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
67
Lin YS, Wang Q, Shen ZK, Sun HX, Wu C, He H, Zou GQ, Xu F, Bu YL, Li JW, Zhao C, Hong M, Lu X, Xu JS, Gao W. Association of Loss of Occlusal Pairs of Teeth with Sarcopenia in a Chinese Population of Community-Dwelling Elderly. J Nutr Health Aging 2022;26:439-444. [PMID: 35587755 DOI: 10.1007/s12603-022-1784-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
68
Xu C, Chen Q, Zhou C, Wu L, Li W, Zhang H, Li Y, Xu F, Xiong J, Wang Q, Zhang H, Jiang Y, Yin H, Wu Q, Dai Q, Hu J, Chen J, Zhang J, Wu G, Wu YL. 98P Camrelizumab as neoadjuvant, first- or later-line treatment for non-small cell lung cancer (NSCLC): A retrospective real-world study (CTONG2004). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.10.116] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]  Open
69
Shi J, Li H, Xu F, Tao X. Materials in advanced design of personal protective equipment: a review. MATERIALS TODAY. ADVANCES 2021;12:100171. [PMID: 34514364 PMCID: PMC8423993 DOI: 10.1016/j.mtadv.2021.100171] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/18/2021] [Revised: 08/26/2021] [Accepted: 09/02/2021] [Indexed: 05/13/2023]
70
Yang RS, Xu F, Wang YM, Zhong WS, Dong L, Shi YN, Tang TJ, Sheng HJ, Jackson D, Yang F. Glutaredoxins regulate maize inflorescence meristem development via redox control of TGA transcriptional activity. NATURE PLANTS 2021;7:1589-1601. [PMID: 34907313 DOI: 10.1038/s41477-021-01029-2] [Citation(s) in RCA: 29] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/23/2020] [Accepted: 10/25/2021] [Indexed: 06/14/2023]
71
Xu F, Baker R, Whitaker T, Luo H, Zhao Y, Stevenson A, Boesch C, Zhang G. Review of good agricultural practices for smallholder maize farmers to minimise aflatoxin contamination. WORLD MYCOTOXIN J 2021. [DOI: 10.3920/wmj2021.2685] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
72
Feng H, Chen Y, Xie Z, Jiang J, Zhong Y, Gao L, Zhou W, Guo W, Yan W, Lv Z, Lu D, Liang H, Xu F, Yang J, Yang X, Zhou Q, Zhang D, Zhang Z, Chuai S, Zhang H, Wu Y, Zhang X. P52.02 High SHP2 Expression Determines the Efficacy of PD-1/PD-L1 Inhibitors in Advanced KRAS Mutant Non-Small Cell Lung Cancer. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
73
Xu F, Li X, Zhang Z, Wu L, Chang CK. Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations. Leuk Res 2021. [DOI: 10.1016/j.leukres.2021.106681.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
74
Wu L, Chen B, Yao W, Li X, Xiao Z, Liu H, Kong Y, Liu L, Xu Y, Wang Q, Li J, Xu F, Xu L, Li K, Song W, Li B, Wang Z, Xia Y. 1300P A phase Ib/II trial of AK104 (PD-1/CTLA-4 bispecific antibody) in combination with anlotinib in advanced NSCLC. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1902] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]  Open
75
Hammond E, Liu Y, Xu F, Liu G, Xi H, Xue L, Bai X, Liao H, Xue S, Zhao S, Zhang A, Kemper J, Afnan M, Mol B, Morbeck D. P–138 When is low quality really low? Should we transfer low-grade blastocysts? Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
PrevPage 3 of 33 123453233Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA